Literature DB >> 5096559

Immunosuppressive therapy in polymyositis.

S Currie, J N Walton.   

Abstract

Immunosuppressive drugs were given to seven patients with polymyositis. The in-vitro activity of peripheral blood lymphocytes had previously been studied in five of these patients with findings suggestive of disturbed immunological processes. Some improvement occurred in five cases, but only in two was the improvement marked and sustained. In this small series of cases, the response to treatment was best in a patient with polymyositis who showed no evidence of involvement of tissues or organs other than muscle and in a second case with subacute polymyositis occurring in association with an unidentified connective tissue disorder. The response was less satisfactory in two patients with dermatomyositis, in two with polymyositis associated with systemic sclerosis, and in one in whom the muscle disorder complicated rheumatoid arthritis. At present such treatment is usually given only in cases which are resistant to, or intolerant of, steroids. The relative values of steroid and immunosuppressive therapy are discussed; a combination of the two in moderate doses may eventually prove to be the best initial treatment for the disorder.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5096559      PMCID: PMC493828          DOI: 10.1136/jnnp.34.4.447

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  Immunosuppressive therapy. The relation between clinical response and immunologic competence.

Authors:  M A Swanson; R S Schwartz
Journal:  N Engl J Med       Date:  1967-07-27       Impact factor: 91.245

2.  Immunological aspects of malignant disease.

Authors:  F M Burnet
Journal:  Lancet       Date:  1967-06-03       Impact factor: 79.321

Review 3.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

4.  Treatment of dermatomyositis with methotrexate.

Authors:  A N Malaviya; A Many; R S Schwartz
Journal:  Lancet       Date:  1968-08-31       Impact factor: 79.321

5.  Herpes-simplex-virus infection after renal transplantation.

Authors:  J Z Montgomerie; D M Becroft; M C Croxson; P B Doak; J D North
Journal:  Lancet       Date:  1969-10-25       Impact factor: 79.321

Review 6.  Chemical suppression of adaptive immunity.

Authors:  A E Gabrielsen; R A Good
Journal:  Adv Immunol       Date:  1967       Impact factor: 3.543

7.  Myxovirus-like structures and accompanying nuclear changes in chronic polymyositis.

Authors:  S M Chou
Journal:  Arch Pathol       Date:  1968-12

8.  Treatment of inflammatory myopathies with azathioprine.

Authors:  D E McFarlin; R C Griggs
Journal:  Trans Am Neurol Assoc       Date:  1968

Review 9.  Myxoviruses and autoimmunity.

Authors:  P Isacson
Journal:  Prog Allergy       Date:  1967

10.  Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis.

Authors:  A L Rose; J N Walton
Journal:  Brain       Date:  1966-12       Impact factor: 13.501

View more
  3 in total

Review 1.  The inflammatory myopathies.

Authors:  J Walton
Journal:  J R Soc Med       Date:  1983-12       Impact factor: 5.344

2.  Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study group.

Authors:  A El-Ghobarey; G Balint; K de Ceulaer; W C Dick; W W Buchanan; T Hadidi; T A Hassan
Journal:  Postgrad Med J       Date:  1978-08       Impact factor: 2.401

3.  Prognosis and treatment of polymyositis with particular reference to steroid resistant patients.

Authors:  M Yoshioka; T Okuno; H Mikawa
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.